VANGUARD GROUP INC 13D and 13G filings for Moleculin Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | VANGUARD GROUP INC | 39,464 0.950% | 10,551 (+36.49%) | Filing |